(알파타우 제공)관련 키워드알파타우이스라엘항암제췌장암 임상FDA 승인문대현 기자 New Study Suggests Ginkgo Biloba Extract May Slow Beta-Amyloid Aggregation in Mild Cognitive Impairm...Wontech Expands Won Ji An's Brand Ambassador Role Across 48 Asian Markets관련 기사알파타우, 美 두경부학회서 '알파다트' 임상 발표
